Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.

Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M.

Biol Chem. 1999 Apr;380(4):431-42.

PMID:
10355629
2.

Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.

Huang X, Poy F, Zhang R, Joachimiak A, Sudol M, Eck MJ.

Nat Struct Biol. 2000 Aug;7(8):634-8.

PMID:
10932245
3.

WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.

Chung W, Campanelli JT.

Mol Cell Biol Res Commun. 1999 Sep-Dec;2(3):162-71.

PMID:
10662592
4.

Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.

Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP.

J Biol Chem. 1995 Nov 10;270(45):27305-10.

5.

Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan.

Rosa G, Ceccarini M, Cavaldesi M, Zini M, Petrucci TC.

Biochem Biophys Res Commun. 1996 Jun 14;223(2):272-7.

PMID:
8670271
6.

The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.

Ilsley JL, Sudol M, Winder SJ.

Cell Signal. 2001 Sep;13(9):625-32.

PMID:
11495720
8.

Interactions between dystrophin and the sarcolemma membrane.

Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C.

Soc Gen Physiol Ser. 1997;52:19-29.

PMID:
9210217
9.

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function.

Yatsenko AS, Kucherenko MM, Pantoja M, Fischer KA, Madeoy J, Deng WM, Schneider M, Baumgartner S, Akey J, Shcherbata HR, Ruohola-Baker H.

BMC Dev Biol. 2009 Feb 27;9:18. doi: 10.1186/1471-213X-9-18.

10.

Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex.

Tommasi di Vignano A, Di Zenzo G, Sudol M, Cesareni G, Dente L.

FEBS Lett. 2000 Apr 14;471(2-3):229-34.

11.

ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan.

Ishikawa-Sakurai M, Yoshida M, Imamura M, Davies KE, Ozawa E.

Hum Mol Genet. 2004 Apr 1;13(7):693-702. Epub 2004 Feb 12.

PMID:
14962982
12.

ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site.

Hnia K, Zouiten D, Cantel S, Chazalette D, Hugon G, Fehrentz JA, Masmoudi A, Diment A, Bramham J, Mornet D, Winder SJ.

Biochem J. 2007 Feb 1;401(3):667-77.

13.

Direct interaction of beta-dystroglycan with F-actin.

Chen YJ, Spence HJ, Cameron JM, Jess T, Ilsley JL, Winder SJ.

Biochem J. 2003 Oct 15;375(Pt 2):329-37.

14.

A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila.

Yatsenko AS, Gray EE, Shcherbata HR, Patterson LB, Sood VD, Kucherenko MM, Baker D, Ruohola-Baker H.

J Biol Chem. 2007 May 18;282(20):15159-69. Epub 2007 Mar 12.

15.

Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.

Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci TC.

Biochem Biophys Res Commun. 2000 Jul 21;274(1):93-8.

PMID:
10903901
16.

The WW domain: linking cell signalling to the membrane cytoskeleton.

Ilsley JL, Sudol M, Winder SJ.

Cell Signal. 2002 Mar;14(3):183-9. Review.

PMID:
11812645
17.

Epitopes in the interacting regions of beta-dystroglycan (PPxY motif) and dystrophin (WW domain).

Pereboev AV, Ahmed N, thi Man N, Morris GE.

Biochim Biophys Acta. 2001 Jul 2;1527(1-2):54-60.

PMID:
11420143
18.

Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells.

Saito F, Masaki T, Kamakura K, Anderson LV, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumura K.

J Biol Chem. 1999 Mar 19;274(12):8240-6.

19.

Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.

James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ.

J Cell Sci. 2000 May;113 ( Pt 10):1717-26.

20.

Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.

Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT.

Neuromuscul Disord. 2003 Jun;13(5):365-75.

PMID:
12798792

Supplemental Content

Support Center